Founded in 2015, Amelioratebiotech operates in Health Tech industry. Initially, the company concentrated on creating diagnostic tests to enhance the speed and accuracy of disease detection. It has suc...
Funding stage:
Angel Round
Last funding:
08/06/2020
Total funding:
$264.87K+
Revenue:
Investors
Employee count:
5
Last 90d
5
Last 90d
Web traffic:
11
11
Last 30d
Last 30d
Amelioratebiotech: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders12
Latest Filing Date30 March 2023- Funding Events24
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Amelioratebiotech
As of 31 March 2023, Amelioratebiotech's equity is held by 11 shareholders, with the top three being Binita Shrivastava Tunga, Rashbehari Tunga, and LV Angel Fund.
Binita Shrivastava Tunga holds the largest stake in Amelioratebiotech at 70.6% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 140.6% equity in Amelioratebiotech.
As of 31 March 2023, investors collectively hold 42.3% equity in Amelioratebiotech.
Amelioratebiotech's ESOP pool stands at 15.2% of total equity as of 31 March 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links